What is Omnitrope?
Omnitrope is Sandoz somatropin: recombinant human growth hormone.
Compare Sandoz Omnitrope HGH cartridge prices and product presentations before you call. The U.S.-labeled Omnitrope Pen 10 system uses a 10 mg cartridge; a listed 15 mg international presentation is not automatically the same product or compatible with that pen.
Omnitrope Pen 10 is associated with the 10 mg/1.5 mL cartridge in U.S. instructions. A 15 mg international listing should not be described as the same cartridge or assumed to fit the U.S. Pen 10. Device compatibility must match the product supplied.
The 10 mg listing and 15 mg international-market listing below are separate presentations. Their differences should not be reduced to milligrams alone; confirm the actual package and injector.
Approximately 30 IU each
| Quantity | Price per unit | Total price |
|---|---|---|
| 2 cartridges | $610 each | $1,220 |
| 5 cartridges | $560 each | $2,800 |
| 7 cartridges | $530 eachbest value | $3,710 |
Approximately 45 IU each • market-specific presentation
| Quantity | Price per unit | Total price |
|---|---|---|
| 1 cartridge | $900 each | $900 |
| 3 cartridges | $860 each | $2,580 |
| 5 cartridges | $820 eachbest value | $4,100 |
Short answers to the questions that come up before the detailed FAQ or a phone call.
Omnitrope is Sandoz somatropin: recombinant human growth hormone.
In the European Union, yes. EMA classifies Omnitrope as a biosimilar to Genotropin.
Yes. Omnitrope was approved in the United States in 2006. Current U.S. cartridge presentations include 5 mg/1.5 mL and 10 mg/1.5 mL.
That is a market-specific commercial presentation and should not be confused with the current U.S. FDA cartridge strengths.
Omnitrope is manufactured by Sandoz and contains somatropin.
Current U.S. FDA records include 5 mg/1.5 mL and 10 mg/1.5 mL cartridges, while other market presentations can differ.
A biosimilar is a biological medicine shown to be highly similar to an already-authorized reference medicine, with no clinically meaningful differences in the evaluated quality, safety and efficacy framework.
Current U.S. cartridge and device labeling ↗ · Sandoz UK 15 mg/1.5 mL product documentation ↗
The UK reference documents a 15 mg/1.5 mL presentation for that market.
Product name and device references: FDA Omnitrope Pen 10 instructions
We show the brand, presentation and price clearly. If treatment is being considered, a licensed physician can review the clinical information and determine whether somatropin is medically appropriate.
English-speaking patient support can answer product, pricing and logistics questions. When treatment is being considered, Dr. Manuel Aguirre Muñoz can review the medical information and explain the next step.
Do not assume that it will. The U.S. Omnitrope Pen 10 instructions specify a 10 mg/1.5 mL cartridge. A different strength or international presentation requires its own verified device instructions.
Yes. Omnitrope is prescription somatropin.
Both contain somatropin. They are separate pharmaceutical products with their own presentations and labeling.
Drug approvals, device configurations and commercial presentations are market-specific. Always match the actual product to its local label and prescription.
Because cost is part of a patient’s decision-making. Pricing transparency and medical appropriateness are separate questions.
Compare the pharmaceutical product first. If you want to go further, our English-speaking patient team can explain current availability, logistics and the medical evaluation process.
Review presentations, manufacturers, and delivery devices side by side.
Compare brands →Understand the difference between daily somatropin and long-acting GH products.
Weekly HGH guide →